Corton Capital’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,498
| Closed | -$110K | – | 260 |
|
|
2024
Q4 | $110K | Sell |
23,498
-34,101
| -59% | -$160K | 0.06% | 340 |
|
|
2024
Q3 | $206K | Buy |
57,599
+31,427
| +120% | +$112K | 0.1% | 365 |
|
|
2024
Q2 | $162K | Buy |
26,172
+13,719
| +110% | +$85.1K | 0.09% | 406 |
|
|
2024
Q1 | $118K | Buy |
+12,453
| New | +$118K | 0.04% | 467 |
|
|
2023
Q2 | – | Sell |
-13,441
| Closed | -$38.3K | – | 464 |
|
|
2023
Q1 | $38.3K | Buy |
13,441
+1,876
| +16% | +$5.35K | 0.03% | 314 |
|
|
2022
Q4 | $84.2K | Buy |
+11,565
| New | +$84.2K | 0.07% | 278 |
|
|
2022
Q3 | – | Sell |
-10,759
| Closed | -$53K | – | 303 |
|
|
2022
Q2 | $53K | Buy |
10,759
+847
| +9% | +$4.17K | 0.05% | 310 |
|
|
2022
Q1 | $234K | Buy |
+9,912
| New | +$234K | 0.1% | 311 |
|